Liangping Xia

2.8k total citations · 1 hit paper
75 papers, 1.9k citations indexed

About

Liangping Xia is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Liangping Xia has authored 75 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 19 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Liangping Xia's work include Colorectal Cancer Treatments and Studies (21 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Genetic factors in colorectal cancer (11 papers). Liangping Xia is often cited by papers focused on Colorectal Cancer Treatments and Studies (21 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Genetic factors in colorectal cancer (11 papers). Liangping Xia collaborates with scholars based in China, United States and Hong Kong. Liangping Xia's co-authors include Wenzhuo He, Chang Jiang, Feng Wang, Jing‐Ping Yun, Feng‐Wei Wang, Rixin Chen, Olivier Déas, Rui‐Hua Xu, Zhizhong Pan and Xiaodan Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Liangping Xia

72 papers receiving 1.8k citations

Hit Papers

N6-methyladenosine modification of circNSUN2 facilitates ... 2019 2026 2021 2023 2019 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis
    2019 537 citations Liangping Xia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangping Xia China 18 956 692 660 311 232 75 1.9k
Francesco Dituri Italy 23 1.4k 1.5× 692 1.0× 788 1.2× 337 1.1× 272 1.2× 62 2.5k
Hou‐Quan Tao China 23 946 1.0× 587 0.8× 466 0.7× 198 0.6× 313 1.3× 77 1.6k
Angelica Calleri Italy 21 853 0.9× 524 0.8× 866 1.3× 386 1.2× 216 0.9× 46 1.8k
Dapeng Li China 20 783 0.8× 443 0.6× 399 0.6× 355 1.1× 209 0.9× 84 1.8k
Hannes Neuwirt Austria 23 787 0.8× 418 0.6× 548 0.8× 313 1.0× 483 2.1× 62 1.8k
Hervé Sartelet France 23 807 0.8× 377 0.5× 527 0.8× 246 0.8× 224 1.0× 82 1.7k
Silvestre Vicent Spain 24 1.1k 1.2× 411 0.6× 721 1.1× 361 1.2× 477 2.1× 40 2.0k
Lydia Nakopoulou Greece 27 1.0k 1.1× 684 1.0× 863 1.3× 321 1.0× 400 1.7× 79 2.3k
Zai‐yuan Ye China 25 907 0.9× 533 0.8× 338 0.5× 174 0.6× 279 1.2× 72 1.6k

Countries citing papers authored by Liangping Xia

Since Specialization
Citations

This map shows the geographic impact of Liangping Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangping Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangping Xia more than expected).

Fields of papers citing papers by Liangping Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangping Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangping Xia. The network helps show where Liangping Xia may publish in the future.

Co-authorship network of co-authors of Liangping Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Liangping Xia. A scholar is included among the top collaborators of Liangping Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangping Xia. Liangping Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lei, Wenzhuo He, Yu Hou, et al.. (2025). Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer. Frontiers in Medicine. 12. 1467871–1467871.
2.
3.
Guo, Hui, et al.. (2024). Leukocyte telomere length decreased the risk of mortality in patients with alcohol-associated liver disease. Frontiers in Endocrinology. 15. 1462591–1462591. 1 indexed citations
4.
Xu, Huaiyuan, Jinxin Hu, YiJiang Song, et al.. (2022). Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma. Frontiers in Cell and Developmental Biology. 9. 780951–780951. 2 indexed citations
5.
Lin, Yujing, et al.. (2022). The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy. Radiotherapy and Oncology. 178. 109414–109414. 2 indexed citations
6.
7.
8.
Lian, Jingyao, et al.. (2020). CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses. SHILAP Revista de lepidopterología. 4 indexed citations
9.
Xie, Jinye, Liangping Xia, Wei Xiang, et al.. (2020). Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1. Proceedings of the National Academy of Sciences. 117(23). 13012–13022. 58 indexed citations
10.
Yang, Lin, Shousheng Liu, Zhenchong Xiong, et al.. (2020). Changes in colorectal cancer incidence by site and age from 1973 to 2015: a SEER database analysis. Aging Clinical and Experimental Research. 33(7). 1937–1946. 7 indexed citations
11.
Wang, Lei, et al.. (2020). Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis. Radiation Oncology. 15(1). 160–160. 3 indexed citations
12.
Liu, Shousheng, Yuanzhong Yang, Chang Jiang, et al.. (2018). Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients. Journal of Translational Medicine. 16(1). 195–195. 16 indexed citations
13.
Jiang, Chang, Yuhua Huang, Jiabin Lu, et al.. (2018). Perivascular cell coverage of intratumoral vasculature is a predictor for bevacizumab efficacy in metastatic colorectal cancer. Cancer Management and Research. Volume 10. 3589–3597. 8 indexed citations
14.
Guo, Guifang, Xiuxing Chen, Wenzhuo He, et al.. (2018). Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data. PLoS ONE. 13(12). e0208547–e0208547. 14 indexed citations
15.
He, Shasha, Yong Chen, Xiaoming Shen, et al.. (2017). DNA-dependent protein kinase catalytic subunit functions in metastasis and influences survival in advanced-stage laryngeal squamous cell carcinoma. Journal of Cancer. 8(12). 2410–2416. 4 indexed citations
16.
Kong, Pengfei, Ruiyan Wu, Chenlu Yang, et al.. (2016). Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric Cancer. Scientific Reports. 6(1). 26313–26313. 14 indexed citations
17.
Kong, Pengfei, Ruiyan Wu, Xuechao Liu, et al.. (2016). The Effects of Anti-inflammatory Drug Treatment in Gastric Cancer Prevention: an Update of a Meta-analysis. Journal of Cancer. 7(15). 2247–2257. 28 indexed citations
18.
He, Wenzhuo, Chang Jiang, Chenxi Yin, et al.. (2015). A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C. OncoTargets and Therapy. 8. 3135–3135. 30 indexed citations
19.
20.
Xia, Liangping, et al.. (2005). Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression. American Journal of Physiology-Renal Physiology. 290(2). F345–F356. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Dituri Breakdown of academic impact, for papers by Hou‐Quan Tao Breakdown of academic impact, for papers by Angelica Calleri Breakdown of academic impact, for papers by Dapeng Li Breakdown of academic impact, for papers by Hannes Neuwirt Breakdown of academic impact, for papers by Hervé Sartelet Breakdown of academic impact, for papers by Silvestre Vicent Breakdown of academic impact, for papers by Lydia Nakopoulou Breakdown of academic impact, for papers by Zai‐yuan Ye
Rankless by CCL
2026